AAPGV (Ascentage Pharma Group Ltd) Yalpi foyda marjasi

Ascentage Pharma Group International (AAPGV) kompaniyasining rasmiy ramzlari

GURU.Markets platformasi tomonidan Ascentage Pharma Group (AAPGV) uchun taqdim etilgan yalpi foyda marjasi darajasi hozirda 83.20 atrofida shakllangan. Ushbu tendentsiya oqsil sintezi va klinik sinovlar bo'yicha tashqi pudratchilarga bo'lgan kritik bog'liqlikni aks ettiradi. AQSh va Xitoy o'rtasidagi savdo ziddiyatlari ushbu xatarlarni kuchaytirib, global dori vositalari sertifikatsiyasini sekinlashtirmoqda. Shu bilan birga, apoptoz ingibitorlari uchun noyob patentlar bozorga kirib kelayotgan yangi ishtirokchilarga qarshi kuchli himoya to'sig'ini yaratadi.

AAPGV - Ascentage Yalpi foyda bo'yicha rentabellik 25.01.2025 - 20.11.2026 oraligʻida

Ascentage (AAPGV) moliyaviy va bozor koʻrsatkichlari kesimi

Ascentage Pharma Group Ltd ishlab chiqargan mahsulot

Yalpi foyda marjasi umumiy daromaddan bevosita xarajatlar chegirib tashlanganidan keyingi foyda ulushini o'lchash orqali ishlab chiqarish samaradorligini belgilaydi. Ascentage Pharma Group (AAPGV) uchun ushbu ko'rsatkich shiddatli global raqobat va patent xatarlari sharoitida dori-darmonlarning yuqori narxlarini saqlab qolish qobiliyatini aks ettiradi. Joriy yalpi foyda marjasi darajasini tahlil qilish orqali investor biznesning geosiyosiy bosimlarga chidamliligini va premium bozorlarga kirish imkoniyatini yo'qotish ehtimolini baholashi mumkin.

Muhim raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Sotuvning yalpi rentabelligi RENB (Renovaro Inc.)|Yalpi rentabellik Mural Oncology PLC (MURA)|Yalpi marja Kairos Pharma (KAPA)|Yalpi rentabellik onkuretherapeutics.com OKUR|GDTC: Sotuvning yalpi rentabelligi|CRIS: Yalpi foyda bo'yicha rentabellik|apollomicsinc.com (APLM) - Yalpi foyda bo'yicha rentabellik|THAR: Yalpi marja|Yalpi foyda bo'yicha rentabellik Advanced Biomed Inc.|Yalpi foyda bo'yicha rentabellik GNPX|Sotuvning yalpi rentabelligi CLDI (Calidi Biotherapeutics)|Yalpi marja SBFM|Xenetic Biosciences, Inc. - Sotuvning yalpi rentabelligi|Yalpi rentabellik Salarius Pharmaceuticals SLRX|Yalpi marja purple-biotech.com PPBT|AONC - Yalpi rentabellik|BGNE: Yalpi rentabellik|CKPT: Yalpi marja|Elevation Oncology - Yalpi foyda normasi|ICAD (iCAD) - Yalpi marja|IKNA: Yalpi foyda normasi|Yalpi rentabellik Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Yalpi foyda normasi|Yalpi rentabellik MorphoSys Corporation MOR|NAYA: Sotuvning yalpi rentabelligi